Abstract
Abstract
Background
We describe the first school-located influenza vaccination campaign with quadrivalent live-attenuated influenza vaccine (LAIV) among pre-school children in Italy, coupled with an innovative school-centred influenza-like illnesses (ILIs) surveillance using a self-sampling non-invasive saliva collection method.
Methods
The pilot study was proposed during the 2021/2022 influenza season to fifteen pre-schools in the Milan municipality. LAIV was offered directly in school to all healthy children without contraindications. ILI differential diagnosis was conducted by real-time RT-PCR for influenza A/B and SARS-CoV-2.
Results
Five pre-schools were involved in the pilot project and overall, 135 families (31.2%) participated in the study, adhering to both surveillance and vaccination; 59% of families had an immigrant background. No pupil experienced adverse reactions after vaccination. Nineteen saliva samples were collected from sixteen children (11.8%). Six samples (31.6%) tested positive for SARS-CoV-2; none was positive for influenza A/B.
Conclusions
The participation in the immunisation campaign was good, considering possible absences due to COVID-19 pandemic, and the intranasal administration was well tolerated and helped to overcome parental hesitancy. Saliva sampling represented a useful tool to reduce children’s stress and increase parents’ compliance. The high participation of families with an immigrant background suggests that school-based interventions can represent an effective strategy to overcome socioeconomic and cultural barriers.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Grosso F, Castrofino A, Del Castillo G, Galli C, Binda S, Pellegrinelli L et al. A comparative study between the incidence and epidemiological features of Influenza-Like Illness and laboratory-confirmed COVID-19 cases in the italian epicenter (Lombardy). J Infect Public Health 2021 May;14(5):674–80. https://doi.org/10.1016/j.jiph.2021.02.003.
2. Candelli M, Pignataro G, Torelli E, Gullì A, Nista EC, Petrucci M et al. Effect of influenza vaccine on COVID-19 mortality: a retrospective study. Intern Emerg Med. 2021 Oct 1;16(7):1849–55. https://doi.org/10.1007/s11739-021-02702-2.
3. Wang R, Liu M, Liu J. The Association between Influenza Vaccination and COVID-19 and its outcomes: a systematic review and Meta-analysis of Observational Studies. Vaccines 2021 May;9(5):529. https://doi.org/10.3390/vaccines9050529.
4. World Health Organization. Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec. 2012 Nov;23(47):461–76.
5. European Centre for Disease Prevention and Control. Influenza virus characterization - Summary Europe, March 2022. 2022 [cited 2022 Jul 26]. Available from: https://www.ecdc.europa.eu/en/publications-data/influenza-virus-characterisation-summary-europe-march-2022.